ORPHAZYME A/S  DK 1000
ORPHAZYME A/S DK 1000
Share · DK0062502894 · A3EYNB (XBER)
Overview
Analyst Grade Summary
gauge-img
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
0
0
0
1
0
No Price
30.10.2025 20:00
Current Prices from ORPHAZYME A/S DK 1000
ExchangeTickerCurrencyLast TradePriceDaily Change
OTC: UTC
UTC
OZYMF
USD
30.10.2025 20:00
90,00 USD
0,00 USD
Share Float & Liquidity
Free Float 27,63 %
Shares Float 11.527,00
Shares Outstanding 41.712,00
Company Profile for ORPHAZYME A/S DK 1000 Share
Orphazyme A/S does not have significant operations. Previously, the company was engaged in the development of therapies for the treatment of neurodegenerative rare diseases. The company was incorporated in 2009 and is headquartered in Copenhagen, Denmark.
Get up to date insights from finAgent about ORPHAZYME A/S DK 1000

Company Data

Name ORPHAZYME A/S DK 1000
Company Orphazyme A/S
Website https://www.orphazyme.com
Primary Exchange XBER Frankfurt
WKN A3EYNB
ISIN DK0062502894
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Jakob Færch Bendtsen
Market Capitalization 47 Mio
Country Denmark
Currency EUR
Employees 0,0 T
Address Ole Maaløes Vej 3, 2200 Copenhagen
IPO Date 2017-11-21

Ticker Symbols

Name Symbol
NASDAQ COPENHAGEN A/S ORPHA.CO
Over The Counter OZYMF
Frankfurt 1TB0.F
More Shares
Investors who hold ORPHAZYME A/S DK 1000 also have the following shares in their portfolio:
LB.HESS.-THR.ZI.DI.04D/18
LB.HESS.-THR.ZI.DI.04D/18 Bond
NYKREDIT 24/27 MTN
NYKREDIT 24/27 MTN Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025